MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF
Cannabis Law Report
FEBRUARY 23, 2022
The cannabis-based drug opportunity is predicted to be over USD$25 billion by 2025, and there are over 20 strong novel cannabinoid-based drugs currently in the late-stage research process. The DMF will enable MediPharm to supply approved API to pharmaceutical companies currently conducting late-stage research. Additional Information.
Let's personalize your content